You are here

Paxlovid fails to improve long COVID symptoms in small study

Primary tabs

...

The findings are part of the STOP-PASC trial, and the study was conducted at Stanford University from November 2022 to September 2023. All enrollees reported at least 3 months of postacute sequelae of SARS-CoV-2 infection (PASC) symptoms.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
howdy folks
Page loaded in 0.436 seconds.